The latest report offers comprehensive analysis of the global influenza vaccines market. The key player assesses that this market will generate revenues of $3.7 billion in 2019.

How this report will benefit you
In this brand new 155-page report you find 64 in-depth tables, charts and graphs – all unavailable elsewhere.

The report provides clear detailed insight into the global Influenza market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Download Free Sample Pages of this report

Report Scope
Thiss new investigation shows revenue predictions at overall world market, submarket, company, product and national level.

This study gives individual analysis for two influenza vaccine submarkets, which are further divided by vaccine technologies:

  • Trivalent Influenza Vaccines (TIV)
  • Quadrivalent Influenza Vaccines (QIV)

Our new analysis also shows you revenue predictions for the vaccines produced by these five market leaders: and their market share

  • AstraZeneca
  • GlaxoSmithKline
  •  Sanofi Pasteur
  • Seqirus
  • Others

Our report analyses the vaccines in research and development and assess their prospects once they enter the market. The R&D pipeline discusses:

  • Seasonal Influenza vaccines in development
  • Universal Influenza vaccines in development

The report includes forecasts to 2029 and analysis of pipeline developments for the following specific vaccines:

  • Fluzone / VaxiGrip
  • Seqirus Influenza Vaccines
  • Fluarix / FluLaval
  • FluMist / Fluenz
  • FluBlok
  • Other

This study shows you forecasts to 2029 of influenza vaccines in developed and developing regions:

  • United States
  • Japan
  • The EU 5 – Germany, France, United Kingdom, Italy and Spain.
  • Brazil, Russia, India and China.
Key Questions Answered by this Report:
  • What is the current size of the total global influenza vaccines market? How much will this market be worth from 2019-2029?
  • What are the main drivers and restraints that will shape the overall influenza vaccines market over the next ten years?
  • What are the main segments within the overall influenza vaccines market? How much will each of these segments be worth for the period 2019-2029? How will the composition of the market change during that time, and why?
  • What factors will affect that industry and market over the next ten years?
  • What are the largest national markets for influenza vaccines? What is their current status and how will they develop over the next ten years? What are their forecasts for 2019-2029?
  • How will political and regulatory factors influence the regional markets?
  • How will the market shares of the national markets change by 2029, and which geographical region will lead the market in 2029?
  • Who are the leading companies and what are their prospects over the forecast period?
  • What are the predictions for existing players and the prospects for new market entrants?
  • What are the leading vaccines? What are their revenues and latest developments?
  • What are some of the most prominent influenza vaccines currently in development?
  • What are the main trends that will affect the influenza vaccines market between 2019 and 2029?
  • What are the main strengths, weaknesses, opportunities and threats for the market?
  • What are the social, technological, economic and political influences that will shape that industry over the next ten years?
  • How will the global influenza vaccines market evolve over the forecasted period, 2019-2029?